Business
Final Results and Annual Report
Final Results and Annual Report.
About this update from Nuformix Plc
[{"type":"text","content":"\n \nRNS Number : 5034R Levrett PLC 22 September 2017 \n\n \n \n22 September 2017 \nLevrett Plc\n(\"Levrett\" or \"the Company\")\n \nFinal Results\nfor the period ended 31 March 2017\n \nLevrett, a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, announces its final results for the period ended 31 March 2017 and posting of Annual Report.\n \n \nEnquiries:\n\n\n\n\nLevrett Plc\nJohn Lidgey, Chairman\n \n\n\n+44 (0) 20 7183 4342\n\n\n\n\nWhitman Howard Limited (Broker and Corporate Advisor)\nNick Lovering\n \n\n\n+44 (0) 20 7659 1234\n\n\n\n\nGable Communications Limited \nJohn Bick\n\n\n+44 (0) 20 7193 7463\ne: [email protected]\n\n\n\n\n \n \nCHAIRMAN'S STATEMENT\n \nFOR THE YEAR ENDED 31 MARCH 2017\n \nLevrett announced on 15 September 2017 the conclusion of this process and that it has entered into a conditional agreement to acquire the entire issued share capital of Nuformix Limited (\"Nuformix\") for a total consideration of £12,000,000 to be settled through the issuance of new ordinary shares in the Company at a price of 4 pence per share (the \"Acquisition\"), subject to Shareholders' approval and Re-admission.\n \nIn addition, the Company announced a Placing, under which it has issued 57,500,000 Placing Shares at 4p per share, raising £2.3 million, conditional, inter alia, upon Re-Admission.\n \nDetails of Proposed Acquisition of Nuformix Limited, the Placing of New Ordinary Shares, Approval of a Waiver of obligation under Rule 9 of the City Code on Takeovers and Mergers and Notice of General Meeting have been published in the Prospectus which has been sent to shareholders.\n \nThe Prospectus has been approved by the UK Listing Authority and is available for inspection at the Financial Conduct...